{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T15:44:08Z","timestamp":1775317448915,"version":"3.50.1"},"reference-count":44,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["015\/16\/W\/ST5\/00413"],"award-info":[{"award-number":["015\/16\/W\/ST5\/00413"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CMMS PAS Grant for Young Scientists","award":["551-91"],"award-info":[{"award-number":["551-91"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Antisense oligonucleotides conjugated with boron clusters (B-ASOs) have been described as potential gene expression inhibitors and carriers of boron for boron neutron capture therapy (BNCT), providing a dual-action therapeutic platform. In this study, we tested the nucleolytic stability of DNA oligonucleotides labeled with metallacarborane [(3,3\u2019-iron-1,2,1\u2019,2\u2019-dicarbollide)(\u22121)]ate [Fe(C2B9H11)2] (FESAN) against snake venom phosphodiesterase (svPDE, 3\u2019\u21925\u2019-exonuclease). Contrary to the previously observed protective effect of carborane (C2B10H12) modifications, the B-ASOs containing a metallacarborane moiety at the 5\u2019-end of the oligonucleotide chain were hydrolyzed faster than their parent nonmodified oligomers. Interestingly, an enhancement in the hydrolysis rate was also observed in the presence of free metallacarborane, and this reaction was dependent on the concentration of the metallacarborane. Microscale thermophoresis (MST) analysis confirmed the high affinity (Kd nM range) of the binding of the metallacarborane to the proteins of crude snake venom and the moderate affinity (Kd \u00b5M range) between the metallacarborane and the short single-stranded DNA. We hypothesize that the metallacarborane complex covalently bound to B-ASO holds DNA molecules close to the protein surface, facilitating enzymatic cleavage. The addition of metallacarborane alone to the ASO\/svPDE reaction mixture provides the interface to attract freely floating DNA molecules. In both cases, the local DNA concentration around the enzymes increases, giving rise to faster hydrolysis. It was experimentally shown that an allosteric effect, possibly attributable to the observed boost in the 3\u2019\u21925\u2019-exonucleolytic activity of snake venom phosphodiesterase, is much less plausible.<\/jats:p>","DOI":"10.3390\/biom10050718","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T04:46:07Z","timestamp":1588826767000},"page":"718","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Metallacarborane Complex Boosts the Rate of DNA Oligonucleotide Hydrolysis in the Reaction Catalyzed by Snake Venom Phosphodiesterase"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9689-777X","authenticated-orcid":false,"given":"Damian","family":"Kaniowski","sequence":"first","affiliation":[{"name":"Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7169-181X","authenticated-orcid":false,"given":"Katarzyna","family":"Kulik","sequence":"additional","affiliation":[{"name":"Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5562-959X","authenticated-orcid":false,"given":"Katarzyna","family":"Ebenryter-Olbi\u0144ska","sequence":"additional","affiliation":[{"name":"Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5325-6072","authenticated-orcid":false,"given":"Ewelina","family":"Wielgus","sequence":"additional","affiliation":[{"name":"Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3158-5796","authenticated-orcid":false,"given":"Zbigniew","family":"Lesnikowski","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology, Polish Academy of Sciences, Laboratory of Medicinal Chemistry, 106 Lodowa St., 92-232 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4084-4334","authenticated-orcid":false,"given":"Barbara","family":"Nawrot","sequence":"additional","affiliation":[{"name":"Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,5,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Crooke, S.T. (2008). Antisense Drug Technology: Principles, Strategies, and Applications, Edition CRC Press. [2nd ed.].","DOI":"10.1201\/9780849387951"},{"key":"ref_2","first-page":"347","article-title":"Antisense oligonucleotides: Basic concepts and mechanisms","volume":"1","author":"Dias","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Liao, W., Dong, J., Peh, H.Y., Tan, L.H., Lim, K.S., Li, L., and Wong, W.F. (2017). Oligonucleotide Therapy for Obstructive and Restrictive Respiratory Diseases. Molecules, 22.","DOI":"10.3390\/molecules22010139"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41418-018-0231-3","article-title":"Function, clinical application, and strategies of Pre-mRNA splicing in cancer","volume":"26","author":"Di","year":"2019","journal-title":"Cell Death Differ."},{"key":"ref_5","first-page":"35","article-title":"RNA therapeutics: RNAi and antisense mechanisms and clinical applications","volume":"7","author":"Chery","year":"2016","journal-title":"Postdoc J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/978-1-4939-8651-4_26","article-title":"Pre-mRNA Splicing Modulation by Antisense Oligonucleotides","volume":"1828","author":"Singh","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/nrg3482","article-title":"Alternative cleavage and polyadenylation: Extent, regulation and function","volume":"14","author":"Elkon","year":"2013","journal-title":"Nat. Rev. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/nat.2019.0779","article-title":"Targeting Translation Termination Machinery with Antisense Oligonucleotides for Diseases Caused by Nonsense Mutations","volume":"29","author":"Huang","year":"2019","journal-title":"Nucleic Acid Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.1074\/jbc.AW118.003232","article-title":"Mechanism of premature translation termination on a sense codon","volume":"32","author":"Svidritskiy","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033583510000181","article-title":"Nucleases: Diversity of structure, function and mechanism","volume":"44","author":"Yang","year":"2011","journal-title":"Q. Rev. Biophys."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1039\/b709797m","article-title":"Recent highlights in modified oligonucleotide chemistry","volume":"5","author":"Cobb","year":"2007","journal-title":"Org. Biomol. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.chembiol.2012.07.011","article-title":"Designing chemically modified oligonucleotides for targeted gene silencing","volume":"19","author":"Deleavey","year":"2012","journal-title":"Chem. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1039\/c3nj00418j","article-title":"Endonuclease and Exonuclease Activities on Oligodeoxynucleotides Containing Spiroiminodihydantoin Depend on the Sequence Context and the Lesion Stereochemistry","volume":"37","author":"Chen","year":"2013","journal-title":"New J. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/abio.1998.2569","article-title":"Base specificity of oligonucleotide digestion by calf spleen phosphodiesterase with matrix-assisted laser desorption ionization analysis","volume":"258","author":"Bentzley","year":"1998","journal-title":"Anal. Biochem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1134\/S0006297910010013","article-title":"An overview on nucleases (DNase, RNase, and phosphodiesterase) in snake venoms","volume":"75","author":"Dhananjaya","year":"2010","journal-title":"Biochemistry Moscow"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1212\/NXG.0000000000000323","article-title":"Antisense oligonucleotides: A primer","volume":"5","author":"Scoles","year":"2019","journal-title":"Neurol. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s13311-013-0194-5","article-title":"Antisense oligonucleotides: Treating neurodegeneration at the level of RNA","volume":"10","author":"DeVos","year":"2013","journal-title":"Neurotherapeutics"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1093\/nar\/gkg820","article-title":"Expanding the design horizon of antisense oligonucleotides with alpha-l-LNA","volume":"31","author":"Frieden","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"16535","DOI":"10.1002\/chem.201702957","article-title":"Versatile Method for the Site-Specific Modification of DNA with Boron Clusters: Anti-Epidermal Growth Factor Receptor (EGFR) Antisense Oligonucleotide Case","volume":"23","author":"Kaniowski","year":"2017","journal-title":"Chem. Eur. J."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kaniowski, D., Ebenryter-Olbi\u0144ska, K., Sobczak, M., Wojtczak, B., Janczak, S., Le\u015bnikowski, Z.J., and Nawrot, B. (2017). High Boron-loaded DNA-Oligomers as Potential Boron Neutron Capture Therapy and Antisense Oligonucleotide Dual-Action Anticancer Agents. Molecules, 22.","DOI":"10.3390\/molecules22091393"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1039\/C9NR06550D","article-title":"Boron clusters as a platform for new materials: Composites of nucleic acids and oligofunctionalized carboranes (C(2)B(10)H(12)) and their assembly into functional nanoparticles","volume":"12","author":"Kaniowski","year":"2020","journal-title":"Nanoscale"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/bc400059y","article-title":"siRNAs modified with boron cluster and their physicochemical and biological characterization","volume":"24","author":"Kwiatkowska","year":"2013","journal-title":"Bioconjug Chem."},{"key":"ref_23","first-page":"35","article-title":"Boron delivery agents for neutron capture therapy of cancer","volume":"38","author":"Barth","year":"2018","journal-title":"Cancer Commun. (Lond.)"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/108729002760070821","article-title":"Carboranyl oligonucleotides. 4. Synthesis, and physicochemical studies of oligonucleotides containing 2\u2019-O-(o-carboran-1-yl)methyl group","volume":"12","author":"Olejniczak","year":"2002","journal-title":"Antisense Nucl. Acid Drug Develop."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"7494","DOI":"10.1021\/ja00096a004","article-title":"Carboranyl Oligonucleotides. 2. Synthesis and Physicochemical Properties of Dodecathymidylate Containing 5-(o-Carboranyl-1-yl)-2\u2019-O-Deoxyuridine","volume":"116","author":"Lesnikowski","year":"1994","journal-title":"J. Am. Chem. Soc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4489","DOI":"10.1002\/ejoc.200300259","article-title":"Boron clusters\u2014A new entity for DNA-oligonucleotide modification","volume":"23","author":"Lesnikowski","year":"2003","journal-title":"Eur. J. Org. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1002\/anie.200352505","article-title":"Nucleoside Conjugate Containing Metallacarborane Group and its Incorporation into DNA-oligonucleotide","volume":"42","author":"Olejniczak","year":"2003","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1139\/V10-175","article-title":"Metallacarboranes for the labelling of DNA\u2014Synthesis of oligonucleotides bearing a 3,3\u2019-iron-1,2,1\u2019,2\u2019-dicarbollide complex","volume":"89","author":"Olejniczak","year":"2011","journal-title":"Can. J. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jorganchem.2013.05.022","article-title":"Synthesis, physicochemical and biochemical studies of anti-IRS-1 oligonucleotides containing carborane and\/or metallacarborane modification","volume":"747","author":"Olejniczak","year":"2013","journal-title":"J. Organomet. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Sanghvi, Y.S. (2011). A status update of modified oligonucleotides for chemotherapeutics applications. Current Protocols in Nucleic Acid Chemistry, John Wiley & Sons, Inc.. Chapter 4, Unit 4.1.1-4.1.22.","DOI":"10.1002\/0471142700.nc0401s46"},{"key":"ref_31","unstructured":"(2020, April 01). Glen Research. Available online: http:\/glenresearch.com\/GlenReports\/GR25-24.html."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Munawar, A., Ali, S.A., Akrem, A., and Betzel, C. (2018). Snake Venom Peptides: Tools of Biodiscovery. Toxins, 10.","DOI":"10.3390\/toxins10110474"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1023\/A:1022414503995","article-title":"Purification and characterization of a phosphodiesterase from Bothrops alternatus snake venom","volume":"21","author":"Corradini","year":"2002","journal-title":"J. Protein Chem."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Ullah, A., Ullah, K., Ali, H., Betzel, C., and Ur Rehman, S. (2019). The Sequence and a Three-Dimensional Structural Analysis Reveal Substrate Specificity Among Snake Venom Phosphodiesterases. Toxins, 11.","DOI":"10.3390\/toxins11110625"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Fayaz, A., Narayan, S.H., and Yinghuai, Z. (2020). Boron Chemistry for Medical Applications. Molecules, 25.","DOI":"10.3390\/molecules25040828"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"17239","DOI":"10.1002\/chem.201803178","article-title":"Metallacarboranes on the Road to Anticancer Therapies: Cellular Uptake, DNA Interaction, and Biological Evaluation of Cobaltabisdicarbollide [COSAN](-)","volume":"24","author":"Fuentes","year":"2018","journal-title":"Chem. Eur. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1016\/j.bmc.2005.04.042","article-title":"Towards new boron carriers for boron neutron capture therapy: Metallacarboranes and their nucleoside conjugates","volume":"13","author":"Paradowska","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"9800","DOI":"10.1038\/s41598-017-10314-0","article-title":"Interactions of Boron Clusters and their Derivatives with Serum Albumin","volume":"7","author":"Fink","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_39","first-page":"1","article-title":"Periphery Decorated and Core Initiated Neutral and Polyanionic Borane large molecules: Forthcoming and Promising properties for medicinal applications","volume":"26","author":"Bennour","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1021\/acs.bioconjchem.8b00646","article-title":"Synthesis and Biological Activity of Thymosin \u03b24-Anionic Boron Cluster Conjugates","volume":"29","author":"Fink","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/nyas.14201","article-title":"Metallacarboranes as a tool for enhancing the activity of therapeutic peptides","volume":"1457","author":"Fink","year":"2019","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1073\/pnas.94.6.2620","article-title":"Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: In vitro and in vivo studies","volume":"94","author":"Agrawal","year":"1997","journal-title":"PNAS U.S.A."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"12820","DOI":"10.1002\/chem.201902796","article-title":"Dual Binding Mode of Metallacarborane Produces a Robust Shield on Proteins","volume":"25","author":"Fuentes","year":"2019","journal-title":"Chem. Eur. J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5741","DOI":"10.1021\/bi953078e","article-title":"Carboranyl Oligonucleotides. 3. Biochemical Properties of Oligonucleotides Containing 5-(o-carboranyl-1-yl)-2\u2019-deoxyuridine","volume":"35","author":"Lesnikowski","year":"1996","journal-title":"Biochemistry"}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/10\/5\/718\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:09:58Z","timestamp":1760364598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/10\/5\/718"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,5]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5]]}},"alternative-id":["biom10050718"],"URL":"https:\/\/doi.org\/10.3390\/biom10050718","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,5]]}}}